| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 496,6 k € | +0.9% | 492,3 k € | +4.2% | 472,3 k € | +0.2% | 471,3 k € | -4.2% | 492,1 k € | +3.8% | 474,2 k € | +8.2% | 438,2 k € | +5.9% | 413,8 k € | -4.4% | 432,8 k € | +18.8% | 364,3 k € | +5.5% | 345,3 k € | -9.7% | 382,4 k € | +17.3% | 326,0 k € | -0.8% | 328,8 k € | +16.1% | 283,1 k € | +9.1% | 259,4 k € | -9.0% | 284,9 k € | +14.1% | 249,8 k € | +9.4% | 228,4 k € | |
| EBITDA | 494,2 k € | +0.9% | 489,9 k € | +4.2% | 470,0 k € | +0.3% | 468,5 k € | -4.3% | 489,4 k € | +3.6% | 472,2 k € | +8.3% | 435,9 k € | +5.9% | 411,6 k € | -4.2% | 429,5 k € | +19.8% | 358,6 k € | +4.9% | 341,9 k € | -9.1% | 376,2 k € | +17.9% | 319,1 k € | -0.8% | 321,5 k € | +17.3% | 274,1 k € | +10.2% | 248,7 k € | -9.5% | 274,8 k € | +14.9% | 239,2 k € | +9.4% | 218,8 k € | |
| Operating profit | 480,1 k € | +1.0% | 475,5 k € | +2.4% | 464,2 k € | +0.3% | 463,0 k € | -2.5% | 474,7 k € | +2.8% | 461,9 k € | +8.3% | 426,4 k € | +5.9% | 402,8 k € | -2.0% | 410,9 k € | +17.9% | 348,4 k € | +5.2% | 331,1 k € | -6.5% | 353,9 k € | +19.7% | 295,6 k € | -3.6% | 306,5 k € | +23.2% | 248,8 k € | +13.2% | 219,8 k € | -10.8% | 246,3 k € | +17.3% | 210,0 k € | +8.4% | 193,7 k € | |
| Profit/loss | 357,0 k € | +1.9% | 350,4 k € | +8.5% | 323,0 k € | +3.2% | 312,8 k € | -2.7% | 321,6 k € | +9.8% | 293,0 k € | +5.2% | 278,4 k € | +16.2% | 239,6 k € | -2.5% | 245,7 k € | +17.7% | 208,8 k € | +706.5% | 25,9 k € | -89.5% | 246,6 k € | +11.5% | 221,1 k € | -0.3% | 221,6 k € | +25.9% | 176,1 k € | +11.2% | 158,4 k € | -5.7% | 168,0 k € | +10.6% | 151,9 k € | +20.3% | 126,2 k € | |
| Equity | 2,2 M € | +5.5% | 2,1 M € | +19.8% | 1,8 M € | +3.8% | 1,7 M € | +22.5% | 1,4 M € | +30.1% | 1,1 M € | +11.6% | 959,1 k € | +40.9% | 680,7 k € | +54.3% | 441,1 k € | +5.4% | 418,3 k € | +99.7% | 209,5 k € | -82.7% | 1,2 M € | +25.5% | 966,1 k € | +29.7% | 745,1 k € | +42.3% | 523,4 k € | -30.0% | 747,4 k € | +26.9% | 589,0 k € | -10.9% | 661,0 k € | +29.8% | 509,1 k € | |
| Total assets | 2,4 M € | +12.1% | 2,1 M € | +11.5% | 1,9 M € | +11.9% | 1,7 M € | +21.4% | 1,4 M € | +17.1% | 1,2 M € | +20.0% | 999,4 k € | +26.9% | 787,7 k € | +24.6% | 632,3 k € | +38.8% | 455,6 k € | +61.2% | 282,6 k € | -79.5% | 1,4 M € | +17.1% | 1,2 M € | +11.3% | 1,1 M € | +3.0% | 1,0 M € | +17.8% | 870,3 k € | -10.8% | 975,5 k € | +15.3% | 846,0 k € | -5.7% | 896,8 k € | |
| Cash | 439,6 k € | +24.7% | 352,5 k € | -80.5% | 1,8 M € | +9.7% | 1,6 M € | +19.0% | 1,4 M € | +17.6% | 1,2 M € | +21.4% | 969,7 k € | +28.9% | 752,3 k € | +27.9% | 588,1 k € | +35.1% | 435,4 k € | +87.6% | 232,1 k € | -45.9% | 429,2 k € | +57.2% | 273,0 k € | +74.5% | 156,4 k € | -34.8% | 240,0 k € | +765.7% | 27,7 k € | -53.6% | 59,7 k € | +73.9% | 34,3 k € | -71.5% | 120,5 k € | |
| Debts | 144,8 k € | +2670.6% | 5,2 k € | -96.2% | 138,2 k € | — | 11,4 k € | -91.0% | 127,4 k € | +273.3% | 34,1 k € | -67.8% | 106,0 k € | -44.2% | 189,8 k € | +427.4% | 36,0 k € | -48.6% | 69,9 k € | -55.6% | 157,4 k € | -21.4% | 200,2 k € | -33.5% | 301,2 k € | -39.0% | 493,8 k € | +309.0% | 120,7 k € | -68.0% | 376,8 k € | +112.3% | 177,5 k € | -53.6% | 382,7 k € | |||
| Staff | — | — | — | — | — | — | — | — | — | 0,1 | — | 0,1 | 0,1 | 0,1 | 0,2 | 0,2 | 0,2 | 0,2 | 0,2 | |||||||||||||||||||
Private limited company · Wevelgem · incorporated on 12/11/1988
Private limited company profitable and well capitalised. Cash position rising (+24.7%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Dr. CALIS B. is a Private limited company incorporated in 1988. Its main activity is: General medical practice activities. Its registered office is in Wevelgem.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette